KRSA
Korsana Biosciences Inc.
KRSA | NASDAQ
$31.16
+$1.02 (+3.38%)
Nov 2, 2026, 2:56 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | 1.03M | 875K | 93K | 81K | 1.81M | 194K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 306K | 711K | 533K | 348K | 3M | 62K |
Cost of Revenue | n/a | 730K | n/a | n/a | n/a | n/a | n/a | n/a | 105K | 44K | n/a | 580K | 339K | 572K | 776K | n/a | 10.22M | 9.74M | 10.46M | 7.03M | 12.05M | n/a |
Gross Profit | n/a | -730K | 1.03M | 875K | 93K | 81K | 1.81M | 194K | -105K | -44K | n/a | -580K | -339K | -572K | -776K | n/a | -9.91M | -9.03M | -9.93M | -6.68M | -9.05M | 62K |
Operating Income | -1.77M | -3.21M | -838K | -1.01M | -1.67M | -1.46M | 502K | -1.13M | -1.38M | -1.62M | -1.8M | -6.02M | -1.87M | -3.28M | -4.46M | -4.52M | -13.43M | -12.98M | -14.34M | -11.29M | -16.18M | -13.4M |
Interest Income | 16K | 32K | 39K | 30K | 31K | 28K | 28K | 42K | 62K | 76K | 101K | 107K | 62K | 88K | 132K | 111K | 45K | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -1.76M | -3.18M | -799K | -976K | -324K | -1.43M | 530K | -723K | -1.32M | -1.54M | -1.69M | -5.91M | -1.8M | -3.19M | -4.32M | -4.41M | -13.39M | -12.98M | -10.78M | -11.29M | -16.18M | -13.4M |
Net Income | -1.76M | -3.18M | -799K | -976K | -324K | -1.43M | 530K | -723K | -1.32M | -1.54M | -1.69M | 7.57M | -4.18M | -6.95M | -7.22M | -10.5M | -13.39M | -12.98M | -10.78M | -11.29M | -16.18M | -13.4M |
Selling & General & Admin | 1.77M | 2.48M | 1.34M | 1.53M | 1.71M | 1.5M | 1.25M | 1.24M | 1.28M | 1.57M | 1.97M | 2.13M | 1.53M | 2.7M | 3.68M | 3.1M | 3.52M | 3.95M | 4.41M | 4.6M | 6.24M | 5.37M |
Research & Development | n/a | 730K | 519K | 348K | 56K | 36K | 56K | 81K | 105K | 44K | 24K | 580K | 339K | 572K | 1.18M | 1.41M | 10.22M | 9.74M | 10.46M | 7.03M | 12.05M | 8.09M |
Other Expenses | n/a | -730K | n/a | n/a | n/a | n/a | n/a | n/a | -105K | -44K | -200K | 2.72M | -339K | -572K | -1.18M | n/a | -10.22M | -9.74M | -10.46M | -7.03M | -11.17M | n/a |
Operating Expenses | 1.77M | 2.48M | 1.86M | 1.88M | 1.77M | 1.54M | 1.3M | 1.32M | 1.28M | 1.57M | 1.8M | 5.44M | 1.53M | 2.7M | 3.68M | 4.52M | 3.52M | 3.95M | 4.41M | 4.6M | 7.12M | 13.46M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1K | 5K | 6K | 4K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 200K | n/a | n/a | n/a | 400K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.77M | 3.21M | 1.86M | 1.88M | 1.77M | 1.54M | 1.3M | 1.32M | 1.38M | 1.62M | 1.8M | 6.02M | 1.87M | 3.28M | 4.46M | 4.52M | 13.74M | 13.7M | 14.87M | 11.63M | 19.18M | 13.46M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 607.29K | 600.71K | 460.71K | 460.71K | 438.71K | 365.14K | 363.7K | 360.86K | 358.57K | 356.29K | 353.45K | 347.86K | 326K | 310.86K | 310.85K | 295.22K | 295.22K | 295.22K | 294.41K | 309.22K | 255.05K | 243.44K |
Shares Outstanding (Diluted) | 607.29K | 600.71K | 460.71K | 460.71K | 438.71K | 365.14K | 363.7K | 360.86K | 358.57K | 356.29K | 353.45K | 347.86K | 326K | 310.86K | 310.85K | 295.22K | 295.22K | 295.22K | 294.41K | 309.22K | 255.05K | 243.44K |
EPS (Basic) | -2.87 | -5.32 | -1.75 | -2.10 | -0.77 | -3.92 | 1.47 | -2.03 | -3.71 | -4.34 | -4.76 | -23.52 | -12.81 | -21.77 | -22.61 | -34.79 | -45.22 | -43.96 | -36.61 | -36.54 | -63.42 | -55.02 |
EPS (Diluted) | -2.87 | -5.32 | -1.75 | -2.10 | -0.77 | -3.92 | 1.47 | -2.03 | -3.71 | -4.34 | -4.76 | -23.52 | -12.81 | -21.77 | -22.61 | -34.79 | -45.22 | -43.96 | -36.61 | -36.54 | -63.42 | -55.02 |
EBITDA | -1.76M | -3.18M | -799K | -976K | -324K | -1.43M | 530K | -723K | -1.32M | -1.54M | -1.68M | -2.69M | -1.79M | -3.17M | -4.32M | -4.41M | -13.37M | -12.93M | -10.73M | -11.24M | -15.18M | -13.14M |
EBIT | -1.76M | -3.18M | -799K | -976K | -324K | -1.43M | 530K | -723K | -1.32M | -1.54M | -1.69M | -2.71M | -1.8M | -3.19M | -4.32M | -4.41M | -13.39M | -12.98M | -10.77M | -11.29M | -15.3M | -13.4M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 16.25K | 16.25K | 16.25K | 16.25K | n/a | n/a | 17K | 48K | 48K | 48K | 118K | 258K |
Add to Watchlist
Select watchlists to add or remove KRSA